KIMBERLY KELLEY: Open Payments
NPI 1750052155 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $447 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| ABBVIE INC. | 2 | $44 |
| PFIZER INC. | 2 | $40 |
| Lilly USA, LLC | 2 | $31 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $18 |
Products named: Wegovy, ZEPBOUND, VRAYLAR, BREZTRI, ALVESCO, PREVNAR 20, FARXIGA, XIFAXAN.
Industry payments across NC — which companies pay providers there.
